AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $590.87m
- $608.89m
- $44.55m
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film
Brief: Aquestive Therapeutics Announces That FDA Will Not Require An Advisory Committee Meeting To Discuss New Drug Application For Anaphylm™
Aquestive Therapeutics rises after $85 million stock sale
Brief: Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
Aquestive Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Aquestive Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm Sublingual Film
Aquestive Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Estée Lauder, Quanta Services
Aquestive Therapeutics Inc reports results for the quarter ended in June - Earnings Summary